The FDA Center for Devices and Radiological Health (CDRH) is warning manufacturers of drug-device combination products of the potential for nitrosamine impurities, which are classified as probable carcinogens associated with forms of cancer. The FDA did not name specific devices or kinds of devices that could be at risk in the letter it sent to…
The post FDA warns device manufacturers of nitrosamine impurities that could cause cancer appeared first on Medical Design and Outsourcing.